Report of Foreign Issuer (6-k)
January 09 2017 - 4:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Section 13a-16 or 15d-16 of the Securities Exchange Act of 1934
For the month of January 2017
Commission File Number: 001-37569
STRONGBRIDGE BIOPHARMA plc
(Exact name of Registrant as specified in its charter)
900 Northbrook Drive
Suite 200
Trevose, PA 19053
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
On January 9, 2017, Matthew Pauls, president and chief executive officer of Strongbridge Biopharma plc (the
Registrant
), is scheduled to present at the 9
th
Annual Biotech Showcase being held at the Hilton San Francisco Union Square in San Francisco, California.
The presentation will be webcast live and available on the Events & Presentations page in the Investor section of the Registrants website at www.strongbridgebio.com. A copy of the materials to be used during the presentation are attached as an exhibit to this Form 6-K.
Exhibits
Exhibit
Number
|
|
Exhibit Table
|
|
|
|
99.1
|
|
Materials used in January 9, 2017 presentation at Biotech Showcase, San Francisco, California.
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Dated: January 9, 2017
|
STRONGBRIDGE BIOPHARMA PLC
|
|
|
|
|
|
By:
|
/s/ Stephen Long
|
|
|
Stephen Long
|
|
|
Chief Legal Officer
|
3
Strongbridge Biopharma (NASDAQ:SBBP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Strongbridge Biopharma (NASDAQ:SBBP)
Historical Stock Chart
From Apr 2023 to Apr 2024